Business Context and Reporting Period
Company: Aziyo Biologics, Inc. (Note: Request metadata listed "Elutia Inc.", but the filing text identifies the registrant as Aziyo Biologics, Inc.)
Filing Type: Form 8-K (Current Report)
Date of Report: July 1, 2021
Reporting Period: Event reported on July 1, 2021, effective June 24, 2021.
Key Financial Metrics
Debt and Liquidity: The Company received notification that the Small Business Administration (SBA) approved the forgiveness of its Paycheck Protection Program (PPP) Loan in full.
Loan Amount: Approximately $3.0 million (principal plus accrued interest).
Remaining Balance: Zero.
Revenue, Profit, Cash Flow, Margins: The filing text does not provide a clear value for these metrics as this report focuses solely on the debt forgiveness event.
Material Changes
- Termination of Material Definitive Agreement: The promissory note with Silicon Valley Bank under the PPP was terminated due to full loan forgiveness.
- Liability Reduction: The Company's debt obligation of approximately $3.0 million was eliminated effective June 24, 2021.
Guidance, Outlook, and Risks
Management Commentary: The filing confirms the successful resolution of the PPP loan obligation previously entered into in May 2020.
Outlook and Risks: The filing text does not provide specific forward-looking guidance, risk factors, or contingencies beyond the confirmation of the loan forgiveness.
Investor Verification Checklist
- Verify the effective date of the loan forgiveness (June 24, 2021) against the Company's latest financial statements to ensure the liability has been removed.
- Confirm the total amount of principal and accrued interest forgiven to assess the impact on the Company's balance sheet and potential tax implications.
- Review subsequent filings to determine if the Company has other outstanding debt obligations or if this forgiveness impacts future borrowing capacity.